Alisol A

CAS No. 19885-10-0

Alisol A ( Alisol-A )

Catalog No. M21447 CAS No. 19885-10-0

Alisol A may be an autophagic inducer it has anti-cancer activity it presents inhibitory effects on cancer cell lines tested(HepG2 MDA-MB-231 and MCF-7 cells).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 90 Get Quote
10MG 131 Get Quote
25MG 219 Get Quote
50MG 326 Get Quote
100MG 489 Get Quote
500MG 1071 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Alisol A
  • Note
    Research use only not for human use.
  • Brief Description
    Alisol A may be an autophagic inducer it has anti-cancer activity it presents inhibitory effects on cancer cell lines tested(HepG2 MDA-MB-231 and MCF-7 cells).
  • Description
    Alisol A may be an autophagic inducer it has anti-cancer activity it presents inhibitory effects on cancer cell lines tested(HepG2 MDA-MB-231 and MCF-7 cells).
  • Synonyms
    Alisol-A
  • Pathway
    Autophagy
  • Target
    Autophagy
  • Recptor
    Autophagy
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    19885-10-0
  • Formula Weight
    490.72
  • Molecular Formula
    C30H50O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:98 mg/mL (199.71 mM)
  • SMILES
    [H][C@@]12[C@@H](O)CC3=C(CC[C@]3(C)[C@@]1(C)CCC1C(C)(C)C(=O)CC[C@]21C)[C@H](C)C[C@H](O)[C@@H](O)C(C)(C)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yu Y et al.In vitro metabolism of alisol A and its metabolites' identification using high-performance liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Dec 15;941:31-7.
molnova catalog
related products
  • Talarozole

    Talarozole is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA). Talarozole inhibits both CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM respectively.Talarozole for the treatment of acne psoriasis and other keratinization disorders.

  • sbp-7455

    SBP-7455 potently inhibited ULK1/2 enzymatic activity in vitro and in cells, reduced the viability of TNBC cells and had oral bioavailability in mice.

  • MPP+ iodide

    MPP+ iodide, the metabolite of a neurotoxin MPTP, causes symptom of Parkinson's disease (PD) in animal models by selectively destroying dopaminergic neurons in substantia nigra.